Clinical efficacy and safety of Tanreqing injection combined with antibiotics versus antibiotics alone in the treatment of pulmonary infection patients after chemotherapy with lung cancer: A systematic review and meta‐analysis. (11th August 2020)

• Record Type: Journal Article
• Authors: Tong, Yuling; Wen, Jianxia; Yang, Tao; Li, Haotian; Wei, Shizhang; Jing, Manyi; Wang, Min; Zou, Wenjun; Zhao, Yanling
• Is Part Of: Phytotherapy research. Volume 35:Number 1(2021)
• Page Start: 122
• Page End: 137
• Publication Date: 2020-08-11
• Subjects: clinical efficacy -- lung cancer -- meta‐analysis -- pulmonary infection -- Tanreqing injection; Materia medica, Vegetable -- Periodicals; Botany, Medical -- Periodicals; Medicinal plants -- Periodicals; Plant Extracts -- therapeutic use -- Periodicals; Plants, Medicinal -- Periodicals; 581.634
• DOI: 10.1002/ptr.6790
• Languages: English
• ISSNs: 0951-418X

Abstract

Abstract : This study aimed to evaluate the efficacy and safety of Tanreqing injection (TRQi) in the treatment of pulmonary infection after chemotherapy in patients with lung cancer. Cochrane Library, PubMed, Web of Science, EMbase, CNKI, VMIS, Wan‐Fang, and CBM databases were comprehensively searched from established to March 2020. randomized controlled trials (RCTs) of TRQi were selected. The evaluation manual of Cochrane RCT was used to evaluate the methodological quality of all included studies, Stata 13.0 and Review Manager 5.3 software was used for meta‐analysis. This study is registered with PROSPERO (CRD42020175533). Eighteen RCTs with a total of 1, 438 patients were met the inclusion criteria. Meta‐analysis showed that compared with antibiotics alone, TRQi plus antibiotics could significantly improve the clinical efficacy, defervescence time, lung rale disappearance time, cough disappearance time, and average hospitalization time, reduce white blood cell, C‐reactive protein, and procalcitonin levels, and adverse reactions. However, due to the small sample size and low quality of the study, more rigorous and more RCTs are needed for further verification. In conclusion, this study provides useful evidence for the efficacy and safety of TRQi combined with antibiotics in the treatment of pulmonary infection after chemotherapy with lung cancer.